Evidence map›Paper›PMID 23245604›Full record

ArticleLancet (London, England)2012

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Rafael Lozano, Mohsen Naghavi, Kyle Foreman, Stephen Lim, Kenji Shibuya, Victor Aboyans, Jerry Abraham, Timothy Adair, Rakesh Aggarwal, Stephanie Y Ahn and 181 more

Erratum issued 15 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Lancet (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 15 registered trials, which are not on this map. Cited by 6,202 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6,202citing papers in PubMed, 10 pooled it
1443.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01872364 completednot on this mapstarted 2013, after this paper: background citation

A Material Cost-Minimization Analysis for Hernia Repairs and Minor Procedures During a Surgical Mission in the Dominican Republic

TypeobservationalSponsorWashington University School of MedicineRan2013 to 2013Enrolled110ConditionsHernia, Hydrocele
NCT02122666 completednot on this mapstarted 2014, after this paper: background citation

Modulating Physiologic Effects Of Phospholipid Metabolism In Obesity And Diabetes; AIM 4: Composition and Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome

TypeobservationalSponsorWashington University School of MedicineRan2014 to 2024Enrolled27ConditionsMetabolic SyndromeArmsmuscle biopsy
NCT02894918 phase4unknown statusnot on this mapstarted 2016, after this paper: background citation

A Randomized, Open-label, Multi-center Clinical Trial to Evaluate Addition of Peginterferon Alfa-2a to CHB Patients Treated With NAs and Achieved HBV DNA<15 IU/ml、HBeAg<100 PEIU/ml、HBsAg Positive and HBsAg<1500 IU/ml.

TypeinterventionalSponsorHenan Provincial People's HospitalRan2016 to 2018Enrolled114ConditionsChronic Hepatitis BArmsPeginterferon alfa-2a
NCT03004482 suspendednot on this mapstarted 2015, after this paper: background citation

Noninvasive Monitoring and Diagnosis of Physiologic Disturbances in Term and Preterm Newborns Using Video Analysis Techniques

TypeobservationalSponsorAmerican University of Beirut Medical CenterRan2015 to 2023Enrolled80ConditionsNeonatal Intensive Care Unit
NCT03084718 phase2completednot on this mapstarted 2017, after this paper: background citation

An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.

TypeinterventionalSponsorChiesi Farmaceutici S.p.A.Ran2017 to 2018Enrolled610ConditionsAsthmaArmsCHF 718 pMDI, Placebo pMDI, Beclomethasone Dipropionate (BDP)
NCT03084796 phase2completednot on this mapstarted 2017, after this paper: background citation

A 6-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 5259 pMDI (HFA Glycopyrronium Bromide Via Pressurized Metered Dose Inhaler) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

TypeinterventionalSponsorChiesi Farmaceutici S.p.A.Ran2017 to 2018Enrolled733ConditionsCOPD, Chronic Obstructive Pulmonary DiseaseArmsCHF 5259, Placebo, Tiotropium Bromide 18 µg Inhalation Capsule
NCT03086460 phase2completednot on this mapstarted 2017, after this paper: background citation

A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects

TypeinterventionalSponsorChiesi Farmaceutici S.p.A.Ran2017 to 2018Enrolled67ConditionsAsthmaArmsCHF 1531 pMDI, Formoterol Inhalation Solution, Placebo pMDI
NCT04007328 phase2 / phase3unknown statusnot on this mapstarted 2019, after this paper: background citation

To Assess the Role of Sphingosine-1-phosphate in the Pathobiology of Pneumonia: Generate a New Strategy for Treatment of Severe Community-acquired Pneumonia

TypeinterventionalSponsorTaipei Medical University WanFang HospitalRan2019 to 2025Enrolled400ConditionsPneumonia, BacterialArmsMethylprednisolone Sodium Succinate, Placebo
NCT04320342 phase3completednot on this mapstarted 2022, after this paper: background citation

A Phase III, 52-week, Multinational, Multicenter, Randomized, Double-blind, 2-arm Parallel Group Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate Plus Glycopyrronium Bromide (CHF 5993) With the Fixed Dose Dual Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate (CHF 1535), Both Administered Via pMDI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

TypeinterventionalSponsorChiesi Farmaceutici S.p.A.Ran2022 to 2026Enrolled3,433ConditionsCOPD, COPD ExacerbationArmsBeclomethasone Dipropionate, Glycopyrronium Bromide, Formoterol Fumarate
NCT04694430 unknown statusnot on this mapstarted 2021, after this paper: background citation

A Integration of Respiratory Medicine and Prevention Multi-center Study to Determine the Prevalence and Influence of Pertussis on Chronic Obstructive Pulmonary Disease Exacerbation in Shenzhen by National Respiratory Diseases Clinical Medicine Research Center

TypeobservationalSponsorShenzhen People's HospitalRan2021 to 2021Enrolled500ConditionsCOPD Exacerbation, PertussisArmsBlood sample, Data collection, Throat swab
NCT05300997 recruitingnot on this mapstarted 2022, after this paper: background citation

Translational Immunodiagnostics in Suspected Stroke (TrImS): A Two-centre, Pragmatic, Prospective, Observational Study

Typeobservational_patient_registrySponsorThe University of Hong KongRan2022 to 2027Enrolled650ConditionsAcute Ischemic Stroke, Haemorrhagic Stroke, Transient Ischemic Attacks, Cardioembolic StrokeArmsBiomarker blood draw and saliva collection
NCT06732791 recruitingnot on this mapstarted 2025, after this paper: background citation

A Comparative Analysis of MGAP and GAP Trauma Scores in Predicting Prognosis for Multiple Trauma Patients: A Prospective Observational Study

TypeobservationalSponsorAl-Nahrain UniversityRan2025 to 2027Enrolled522ConditionsTrauma
NCT07039123 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Polygenic Risk Score to Optimize Primary Prevention in Intermediate Risk Population (PERSONAL)

TypeinterventionalSponsorUniversity of BernRan2025 to 2027Enrolled205ConditionsPrimary Prevention of Cardiovascular DiseaseArmsPolygenic Risk Score for Coronary Artery Disease (PRS-CAD), Standardized Risk Communication Tool (SCORE2)
NCT07279298 active not recruitingnot on this mapstarted 2026, after this paper: background citation

Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection Associated With Respiratory Syncytial Virus-RSV- in Infants Under 6 Months of Age in Bogotá: a Case-control Study With a Negative Test Design

TypeobservationalSponsorBogotá District Health SecretariatRan2026 to 2027Enrolled1,097ConditionsRespiratory Syncytial Virus Infections, Severe Acute Respiratory Infection, Bronchiolitis, Viral, Viral Respiratory Tract InfectionArmsRSVpreF vaccine (Abrysvo) and Nirsevimab (Beyfortus) or unexposed
NCT07470749 recruitingnot on this mapstarted 2025, after this paper: background citation

Frequency of MAFLD and Its Association With Nutritional Status and Metabolic Risk Factors in a Rural Population of Bangladesh

TypeobservationalSponsorBangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshRan2025 to 2026Enrolled1,000ConditionsMAFLD, Metabolic Abnormalities, Obesity & Overweight
3 · Its place in the literature

Who cites it

6,202 citing papers in PubMed, 10 syntheses or guidelines pooled it, 14,167 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

6,142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

191 authors at 20 institutions in 29 countries.

Rafael LozanoInstitute for Health Metrics and Evaluation, Seattle, WA, USA.
Mohsen Naghavi
Kyle Foreman
Stephen Lim
Kenji Shibuya
Victor Aboyans
Jerry Abraham
Timothy Adair
Rakesh Aggarwal
Stephanie Y Ahn
Miriam Alvarado
H Ross Anderson
Laurie M Anderson
Kathryn G Andrews
Charles Atkinson
Larry M Baddour
Suzanne Barker-Collo
David H Bartels
Michelle L Bell
Emelia J Benjamin
Derrick Bennett
Kavi Bhalla
Boris Bikbov
Aref Bin Abdulhak
Gretchen Birbeck
Fiona Blyth
Ian Bolliger
Soufiane Boufous
Chiara Bucello
Michael Burch
Peter Burney
Jonathan Carapetis
Honglei Chen
David Chou
Sumeet S Chugh
Luc E Coffeng
Steven D Colan
Samantha Colquhoun
K Ellicott Colson
John Condon
Myles D Connor
Leslie T Cooper
Matthew Corriere
Monica Cortinovis
Karen Courville de Vaccaro
William Couser
Benjamin C Cowie
Michael H Criqui
Marita Cross
Kaustubh C Dabhadkar
Nabila Dahodwala
Diego De Leo
Louisa Degenhardt
Allyne Delossantos
Julie Denenberg
Don C Des Jarlais
Samath D Dharmaratne
E Ray Dorsey
Tim Driscoll
Herbert Duber
Beth Ebel
Patricia J Erwin
Patricia Espindola
Majid Ezzati
Valery Feigin
Abraham D Flaxman
Mohammad H Forouzanfar
Francis Gerry R Fowkes
Richard Franklin
Marlene Fransen
Michael K Freeman
Sherine E Gabriel
Emmanuela Gakidou
Flavio Gaspari
Richard F Gillum
Diego Gonzalez-Medina
Yara A Halasa
Diana Haring
James E Harrison
Rasmus Havmoeller
Roderick J Hay
Bruno Hoen
Peter J Hotez
Damian Hoy
Kathryn H Jacobsen
Spencer L James
Rashmi Jasrasaria
Sudha Jayaraman
Nicole Johns
Ganesan Karthikeyan
Nicholas Kassebaum
Andre Keren
Jon-Paul Khoo
Lisa Marie Knowlton
Olive Kobusingye
Adofo Koranteng
Rita Krishnamurthi
Michael Lipnick
Steven E Lipshultz
Summer Lockett Ohno
Jacqueline Mabweijano
Michael F MacIntyre
Leslie Mallinger
Lyn March
Guy B Marks
Robin Marks
Akira Matsumori
Richard Matzopoulos
Bongani M Mayosi
John H McAnulty
Mary M McDermott
John McGrath
George A Mensah
Tony R Merriman
Catherine Michaud
Matthew Miller
Ted R Miller
Charles Mock
Ana Olga Mocumbi
Ali A Mokdad
Andrew Moran
Kim Mulholland
M Nathan Nair
Luigi Naldi
K M Venkat Narayan
Kiumarss Nasseri
Paul Norman
Martin O'Donnell
Saad B Omer
Katrina Ortblad
Richard Osborne
Doruk Ozgediz
Bishnu Pahari
Jeyaraj Durai Pandian
Andrea Panozo Rivero
Rogelio Perez Padilla
Fernando Perez-Ruiz
Norberto Perico
David Phillips
Kelsey Pierce
C Arden Pope
Esteban Porrini
Farshad Pourmalek
Murugesan Raju
Dharani Ranganathan
Jürgen T Rehm
David B Rein
Guiseppe Remuzzi
Frederick P Rivara
Thomas Roberts
Felipe Rodriguez De León
Lisa C Rosenfeld
Lesley Rushton
Ralph L Sacco
Joshua A Salomon
Uchechukwu Sampson
Ella Sanman
David C Schwebel
Maria Segui-Gomez
Donald S Shepard
David Singh
Jessica Singleton
Karen Sliwa
Emma Smith
Andrew Steer
Jennifer A Taylor
Bernadette Thomas
Imad M Tleyjeh
Jeffrey A Towbin
Thomas Truelsen
Eduardo A Undurraga
N Venketasubramanian
Lakshmi Vijayakumar
Theo Vos
Gregory R Wagner
Mengru Wang
Wenzhi Wang
Kerrianne Watt
Martin A Weinstock
Robert Weintraub
James D Wilkinson
Anthony D Woolf
Sarah Wulf
Pon-Hsiu Yeh
Paul Yip
Azadeh Zabetian
Zhi-Jie Zheng
Alan D Lopez
Christopher J L Murray
Mohammad A AlMazroa
Ziad A Memish
Institute for Health Metrics and Evaluation · USUniversity of Washington · USMario Negri Institute for Pharmacological Research · ITBrandeis University · USEmory University · USHarvard University · USImperial College London · GBMayo Clinic in Arizona · USThe University of Sydney · AUUniversity of Miami · USAuckland University of Technology · NZCedars-Sinai Medical Center · USJames Cook University · AUKing Fahd Medical City · SAMassachusetts Department of Public Health · USMenzies School of Health Research · AUUniversity of California San Diego · USAlfaisal University · SAAll India Institute of Medical Sciences · INAtlanta Public Schools · US

Funding

Prospective studies on Parkinson's diseaseZIAES101986 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CHEN, HONGLEI · 2009 to 2016
$7.9M
Mechanisms of health disparities in parkinsonismK23AG034236 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAHODWALA, NABILA · 2010 to 2014
$793k
Forecasting the Cardiovascular Disease Epidemic in ChinaK08HL089675 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MORAN, ANDREW EDWARD · 2008 to 2012
$650k
Intramural NIH HHSMedical Research Council G0901214NHLBI NIH HHS K08 HL089675NIA NIH HHS K23 AG034236
6 · The paper itself

Abstract

backgroundReliable and timely information on the leading causes of death in populations, and how these are changing, is a crucial input into health policy debates. In the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010), we aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex.

methodsWe attempted to identify all available data on causes of death for 187 countries from 1980 to 2010 from vital registration, verbal autopsy, mortality surveillance, censuses, surveys, hospitals, police records, and mortuaries. We assessed data quality for completeness, diagnostic accuracy, missing data, stochastic variations, and probable causes of death. We applied six different modelling strategies to estimate cause-specific mortality trends depending on the strength of the data. For 133 causes and three special aggregates we used the Cause of Death Ensemble model (CODEm) approach, which uses four families of statistical models testing a large set of different models using different permutations of covariates. Model ensembles were developed from these component models. We assessed model performance with rigorous out-of-sample testing of prediction error and the validity of 95% UIs. For 13 causes with low observed numbers of deaths, we developed negative binomial models with plausible covariates. For 27 causes for which death is rare, we modelled the higher level cause in the cause hierarchy of the GBD 2010 and then allocated deaths across component causes proportionately, estimated from all available data in the database. For selected causes (African trypanosomiasis, congenital syphilis, whooping cough, measles, typhoid and parathyroid, leishmaniasis, acute hepatitis E, and HIV/AIDS), we used natural history models based on information on incidence, prevalence, and case-fatality. We separately estimated cause fractions by aetiology for diarrhoea, lower respiratory infections, and meningitis, as well as disaggregations by subcause for chronic kidney disease, maternal disorders, cirrhosis, and liver cancer. For deaths due to collective violence and natural disasters, we used mortality shock regressions. For every cause, we estimated 95% UIs that captured both parameter estimation uncertainty and uncertainty due to model specification where CODEm was used. We constrained cause-specific fractions within every age-sex group to sum to total mortality based on draws from the uncertainty distributions.

findingsIn 2010, there were 52·8 million deaths globally. At the most aggregate level, communicable, maternal, neonatal, and nutritional causes were 24·9% of deaths worldwide in 2010, down from 15·9 million (34·1%) of 46·5 million in 1990. This decrease was largely due to decreases in mortality from diarrhoeal disease (from 2·5 to 1·4 million), lower respiratory infections (from 3·4 to 2·8 million), neonatal disorders (from 3·1 to 2·2 million), measles (from 0·63 to 0·13 million), and tetanus (from 0·27 to 0·06 million). Deaths from HIV/AIDS increased from 0·30 million in 1990 to 1·5 million in 2010, reaching a peak of 1·7 million in 2006. Malaria mortality also rose by an estimated 19·9% since 1990 to 1·17 million deaths in 2010. Tuberculosis killed 1·2 million people in 2010. Deaths from non-communicable diseases rose by just under 8 million between 1990 and 2010, accounting for two of every three deaths (34·5 million) worldwide by 2010. 8 million people died from cancer in 2010, 38% more than two decades ago; of these, 1·5 million (19%) were from trachea, bronchus, and lung cancer. Ischaemic heart disease and stroke collectively killed 12·9 million people in 2010, or one in four deaths worldwide, compared with one in five in 1990; 1·3 million deaths were due to diabetes, twice as many as in 1990. The fraction of global deaths due to injuries (5·1 million deaths) was marginally higher in 2010 (9·6%) compared with two decades earlier (8·8%). This was driven by a 46% rise in deaths worldwide due to road traffic accidents (1·3 million in 2010) and a rise in deaths from falls. Ischaemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), lower respiratory infections, lung cancer, and HIV/AIDS were the leading causes of death in 2010. Ischaemic heart disease, lower respiratory infections, stroke, diarrhoeal disease, malaria, and HIV/AIDS were the leading causes of years of life lost due to premature mortality (YLLs) in 2010, similar to what was estimated for 1990, except for HIV/AIDS and preterm birth complications. YLLs from lower respiratory infections and diarrhoea decreased by 45-54% since 1990; ischaemic heart disease and stroke YLLs increased by 17-28%. Regional variations in leading causes of death were substantial. Communicable, maternal, neonatal, and nutritional causes still accounted for 76% of premature mortality in sub-Saharan Africa in 2010. Age standardised death rates from some key disorders rose (HIV/AIDS, Alzheimer's disease, diabetes mellitus, and chronic kidney disease in particular), but for most diseases, death rates fell in the past two decades; including major vascular diseases, COPD, most forms of cancer, liver cirrhosis, and maternal disorders. For other conditions, notably malaria, prostate cancer, and injuries, little change was noted.

interpretationPopulation growth, increased average age of the world's population, and largely decreasing age-specific, sex-specific, and cause-specific death rates combine to drive a broad shift from communicable, maternal, neonatal, and nutritional causes towards non-communicable diseases. Nevertheless, communicable, maternal, neonatal, and nutritional causes remain the dominant causes of YLLs in sub-Saharan Africa. Overlaid on this general pattern of the epidemiological transition, marked regional variation exists in many causes, such as interpersonal violence, suicide, liver cancer, diabetes, cirrhosis, Chagas disease, African trypanosomiasis, melanoma, and others. Regional heterogeneity highlights the importance of sound epidemiological assessments of the causes of death on a regular basis.

fundingBill & Melinda Gates Foundation.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsCause of DeathChildChild, PreschoolFemaleGlobal HealthHumansInfantInfant, NewbornMaleMiddle AgedMortality

Identifiers

PMID23245604
PMCPMC10790329
OpenAlexW2125065061

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 9 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.